CellFE
CellFE is a venture-backed company with a mission to make advanced therapies accessible to all by transforming the way gene therapies are manufactured. The company uses a microfluidics-based cell engineering platform that can be adapted universally to enable low-cost, high-yield manufacturing of cell and gene therapies at scale. CellFE’s executive team is composed of members who bring strong expertise in the theoretical and practical aspects of the technology, as well as experience in leadership and business operations. CellFE’s research and development efforts are led by world-class scientists who are passionate about using microfluidics to transform how cell and gene therapies are manufactured.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Clinical Services
- Market Focus:
- Nationally (across the country)
Partner with CellFE
We believe microfluidics holds the key to transform manufacturing processes for cell and gene therapies as well as bioprocessing to make higher quality products at a lower cost. Our research and development programs cover applications areas ranging from:
- Traditional cell and gene therapy with a focus on cell engineering applications, including immune and stem cell engineering for clinical use (CAR-T, TCR, cell-based vaccines) and advanced cell diagnostics.
- Bioprocess including virus free transfection of cells
- Delivery of contrast agents for cell tracking
CellFE is developing a platform technology applicable to these and many more applications yet to be explored.
Our Technology Access Program provides partners with early access to our technology which is then optimized to their specific workflow.
